Q2FY25: Cipla reports 15.2% rise in net profit to Rs 1303 crore; Slow growth reported in acute category

Pharma major Cipla on Tuesday announced its unaudited consolidated financial results for the quarter ended September 30th, 2024.

The company reported an 15.2 percent year-on-year rise in its consolidated net profit for the fiscal’s second quarter ended September (Q2FY25) to Rs. 1,303.53 crore.

The company had reported a profit of Rs. 1,177.64 crore in the year-ago period. Moreover, the consolidated net profit was up 10.6 percent.

Also Read Bajaj Finserv Q2 Results: Profit rises by 8.2% to Rs 2,086.97 crore, revenue up 29.5% YoY Nestle Q2 Results: Maggi-maker posts marginal decline in profit at Rs 899.49 crore but beats estimates, revenue up 1.3% YoY L&T Tech posts Q2 profit at Rs 319.60 crore, revenue rises by 7.8% YoY; FY25 guidance maintained IREDA’s net profit surges 36 per cent on-year in Q2FY25

According to the company’s statement, the Cipla’s consolidated revenue from operations stood at Rs. 7,051.02 crores during the quarter ended September from Rs.6,678.15 crore in Q2FY24, a year-on-year jump of nearly 10.5 percent.

One India Business grew at 5 percent YoY. Branded Prescription business continued to outpace the market in key Chronic therapies. CHL delivered strong growth at 21% YoY. The business however, witnessed a historically slow seasonal growth in Acute category impacting both Branded Prescription and Trade Generics business, the company stated.

Meanwhile, the North America business delivered quarterly revenue of $ 237 Mn up by 4% YoY supported by traction in differentiated portfolio.

In the One Africa business, the North Africa business which was a part of Emerging markets and Europe is now merged with SAGA region which is renamed as One Africa. Momentum continues with overall revenue growth at 22 percent.

Emerging Markets and Europe posted a robust revenue growth of 18% in USD terms. Additionally, R&D investments stood at Rs. 385 Crore or 5.5 percent of sales, higher by 2 percent YoY driven by product filings and developmental efforts.

The company has Net cash position of INR 7,950 Cr and debt primarily includes lease liabilities and working capital requirements.

Also ReadQ2 Result 2024 Live Updates: Maruti Suzuki India, Adani Enterprises, Cipla, Marico, V-Mart, others releasing Q2 report today

“I am pleased to share that we continue to make considerable progress across our focused markets.

 » Read More

Related Articles

HYBRID FUNDS: Made to handle market turbulence

AMID THE UNPREDICTABILITY of market cycles, hybrid funds stand out as a versatile investment vehicle. Whether an investor is seeking resilience in volatile times or relative consistency in performance, hybrid funds have the potential to be a compelling choice for building a robust financial future. By combining the growth potential of equities with the stability

EXPLAINER | Specialised Investment Fund: Why the new asset class is made for the moderate risk-taker

Specialised investment fund, the new asset class notified by the Securities and Exchange Board of India, is expected to attract investors who have the ability to take higher risks yet may not want to go the whole hog by investing in unregulated instruments. FE gets into the nitty-gritties of this new option l  What prompted

CGHS facilities extended for THESE central govt employees – Check fresh guidelines

CGHS Facilities Extension: The Centre has issued guidelines and FAQs on the extension of Central Government Health Scheme (CGHS) facilities to all serving and retired employees of Kendriya Vidyalaya Sangathan (KVS). The details include clarifications on the application process, subscription payments, and the roles of various regional offices involved. FAQs on CGHS for KVS Employees:

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

HYBRID FUNDS: Made to handle market turbulence

AMID THE UNPREDICTABILITY of market cycles, hybrid funds stand out as a versatile investment vehicle. Whether an investor is seeking resilience in volatile times or relative consistency in performance, hybrid funds have the potential to be a compelling choice for building a robust financial future. By combining the growth potential of equities with the stability

EXPLAINER | Specialised Investment Fund: Why the new asset class is made for the moderate risk-taker

Specialised investment fund, the new asset class notified by the Securities and Exchange Board of India, is expected to attract investors who have the ability to take higher risks yet may not want to go the whole hog by investing in unregulated instruments. FE gets into the nitty-gritties of this new option l  What prompted

CGHS facilities extended for THESE central govt employees – Check fresh guidelines

CGHS Facilities Extension: The Centre has issued guidelines and FAQs on the extension of Central Government Health Scheme (CGHS) facilities to all serving and retired employees of Kendriya Vidyalaya Sangathan (KVS). The details include clarifications on the application process, subscription payments, and the roles of various regional offices involved. FAQs on CGHS for KVS Employees:

Epigamia co-founder Rohan Mirchandani passes away at 42 due to sudden cardiac arrest

Rohan Mirchandani, co-founder of Epigamia, India’s leading Greek yogurt brand, passed away at the age of 42 due to cardiac arrest. The news was confirmed by Epigamia’s parent company, Drums Food International. “All of us at the Epigamia family will deeply mourn this loss. Rohan was our mentor, friend, and leader. We remain steadfast in

Identical Brains Studios IPO Allotment: How to check the allotment status online on NSE, BSE, Bigshare Services

Identical Brains Studios IPO allotment status online: We are at the final two weeks of 2024 but the Indian stock market remains abuzz with IPOs grabbing investor attention. Among the other IPOs in the pipeline, the NSE SME issue, Identical Brains Studios, which opened on December 18 and closed on December 20, is likely to